PDA Technical Report 13 (TR13) provides guidance on pharmaceutical stability testing, a critical aspect of ensuring the quality and safety of pharmaceutical products. This report, published by the Parenteral Drug Association (PDA), outlines best practices for stability testing, including protocols, procedures, and data analysis. In this guide, we'll walk you through the key aspects of TR13 and provide information on how to access the report.
PDA Technical Report 13 provides valuable guidance on pharmaceutical stability testing, a critical aspect of ensuring the quality and safety of pharmaceutical products. By following the guidelines outlined in TR13, manufacturers and testing laboratories can ensure that their stability testing programs are effective and compliant with regulatory requirements. We hope this guide has been helpful in providing information on accessing and understanding PDA TR13.